QQ客服 官方微博 反馈留言

	Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016?2019)
	Dong, Yue; Zhao, Tong; Ai, Wei; Zalloum, Waleed A.; Kang, Dongwei; Wu, Ting; Liu, Xinyong; Zhan, Peng
刊名	EXPERT OPINION ON THERAPEUTIC PATENTS
	2019
卷号	29期号:11页码:871-879
关键词	URAT1 inhibitors lesinurad RDEA3170 SHR4640 benzbromarone sulfonamide dual inhibitor gout hyperuricemia
DOI	10.1080/13543776.2019.1676727
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4557858
专题	山东大学
作者单位	Shandong Univ, Sch Pharmaceut Sci, Minist Educ, Key Lab Chem Biol,Dept Med C
推荐引用方式 GB/T 7714	Dong, Yue,Zhao, Tong,Ai, Wei,et al. Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016?2019)[J]. EXPERT OPINION ON THERAPEUTIC PATENTS,2019,29(11):871-879.
APA	Dong, Yue.,Zhao, Tong.,Ai, Wei.,Zalloum, Waleed A..,Kang, Dongwei.,...&Zhan, Peng.(2019).Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016?2019).EXPERT OPINION ON THERAPEUTIC PATENTS,29(11),871-879.
MLA	Dong, Yue,et al."Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016?2019)".EXPERT OPINION ON THERAPEUTIC PATENTS 29.11(2019):871-879.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。